Farmak has become a leader in pharmacy sales, in monetary terms, in the first half of 2017 among marketing сompanies in Ukraine.
These are the findings published by Proxima Research based on the data from the market research system PharmXplorer / Pharmstandard.
“Our main objective is to provide people with high quality and effective medicines. More than 2500 Farmak's employees in Ukraine work to achieve this objective day after day. The high rating result once again proves that we have chosen a right direction and it emphasizes the effectiveness of our work”, says Augustin Dubnička, Executive Director, Farmak.
It is worth to mention that in 2015 and 2016 Farmak was also a leader in pharmacy sales, in monetary terms, for the same period*.
*According to Proxima Research.
Volodymyr Kostiuk, Executive Director of “Farmak”, has ranked the best top managers in his field of work. Volodymyr Kostiuk has been employed by “Farmak” since 2008 and appointed as the Executive Director in 2012. The strategic task of Volodymyr Kostiuk is to strengthen the positions of JSC “Farmak” in the international markets, expand the geography [&helli...
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]